Favorable evolution post hematologous stem cell transplant after primary central nervous system lymphoma in a multiple sclerosis under natalizumab

A. Fromont; R.O. Casasnovas; C. Billy; L. Martin; Thibault Moreau

Poster

Favorable evolution post hematologous stem cell transplant after primary central nervous system lymphoma in a multiple sclerosis under natalizumab

A. Fromont ¹ R.O. Casasnovas ² C. Billy ³ L. Martin ⁴ Thibault Moreau ¹

1 Service de Neurologie générale, vasculaire et dégénérative (CHU de Dijon)

2 Service d'hématologie biologique (CHU de Dijon)

3 Centre Hospitalier d'Auxerre

4 Service de Pathologie [CHU de Dijon]

Type de document :

Poster

Domaine :

Sciences du Vivant [q-bio] / Neurosciences [q-bio.NC]

Liste complète des métadonnées

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01678280
Contributeur : Lnc - Université de Bourgogne <>
Soumis le : mardi 9 janvier 2018 - 10:42:39
Dernière modification le : jeudi 11 mars 2021 - 10:32:02

A. Fromont, R.O. Casasnovas, C. Billy, L. Martin, Thibault Moreau. Favorable evolution post hematologous stem cell transplant after primary central nervous system lymphoma in a multiple sclerosis under natalizumab . 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Oct 2017, Paris, France. Multiple Sclerosis Journal 2017; 23: (S3) 680–975, 23 (S3), pp.EP1760. ⟨hal-01678280⟩

Favorable evolution post hematologous stem cell transplant after primary central nervous system lymphoma in a multiple sclerosis under natalizumab

Identifiants

Collections

Citation

Exporter

Métriques

53

Favorable evolution post hematologous stem cell transplant after primary central nervous system lymphoma in a multiple sclerosis under natalizumab

Identifiants

Collections

Citation

Exporter

Partager

Métriques

53